Citi Maintains a 'Sell' on Cross Country Healthcare (CCRN); Believe Shares Will Continue to Underperform
More News related to CCRN
- Cross Country Healthcare (CCRN) Reports Mixed Q3 Results; Guides Q4
- Cross Country Healthcare Reports Third Quarter 2009 Results
- Cross Country Healthcare to Present at Oppenheimer Healthcare Conference and Participate in SunTrust Robinson Humphrey Business Services Unconference
- Globalequityreport.com Announces an Investment Report Featuring Healthcare Services Company SK3 Group, Inc.
- SunTrust Upgrades Cross Country Healthcare (CCRN) to Buy
More News related to Analyst Comments
- JANCO Partners Downgrades Energy Conversion Devices (ENER) to Sell
- Feltl & Co. Downgrades ArcSight (ARST) to Sell
- Credit Suisse Downgrades Comcast (CMCSA) to Neutral
- Citi Downgrades AK Steel (AKS) to Hold
- Citi Downgrades Netflix (NFLX) to Hold
Citi maintains a 'Sell' on Cross Country Healthcare Inc (Nasdaq: CCRN). Price target $8.
Citi analyst says, "We expect the shares to underperform over the next 12 months because consensus forward estimates are likely too high and our modest growth estimates don't support a higher 12-month valuation. In other words, the market has not completely discounted the risk of a slowing economy and slowing hospital demand."
Cross Country Healthcare, Inc. (Cross Country) is a provider of healthcare staffing services in the United States, a global provider of clinical trials services to pharmaceutical and biotechnology customers, as well as a provider of other human capital management services focused on healthcare.
Related Categories
Analyst CommentsStocks Mentioned
+0.38Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
